FdaApplication
ANDA 214182
Identifiers
- fda_app_no: ANDA214182
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LTD |
| application_type | ANDA |
| approval_date | 2021-02-11 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 7.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 2.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 10MG | TABLET;ORAL |
4 products